Skip to content

German Register of Outpatient Parenteral Antibiotic Therapy

German Register of Outpatient Parenteral Antibiotic Therapy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04413396
Acronym
OPATReg
Enrollment
600
Registered
2020-06-02
Start date
2019-10-01
Completion date
2023-06-30
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implementation of OPAT in Germany

Brief summary

Many infectious diseases require a therapy that is administered intravenously due to a lack of oral treatments. Affected patients often have to stay weeks or even months in hospital just for receiving their therapy although they do not feel severely unwell. Outpatient parenteral antibiotic therapy (OPAT) allows these patients under certain requirements to get discharged from hospital and apply the antibiotic treatment on their own. For these patients quality of life improves by feeling more comfortable at home and being able to participate in everyday life or even go back to work. For the hospitals a reduced inpatient health care means a clear reduction of costs. The aim of OPATReg is to examine under which conditions the OPAT can be established at different locations of patient care. For this purpose, patients with APAT are to be treated and data collected at 7 university institutions in Germany. All centers have the expertise to provide comprehensive care for patients with infectious diseases, to transfer them from inpatient to outpatient care and to continue to provide care there. If successful, the project should help to identify the potential of OPAT for all of Germany. If positive effects and feasibility can be demonstrated OPAT could become an important therapy option with many advantages for certain patients.

Interventions

Application of outpatient parenteral antibiotic therapy in patients with infectious diseases to allow them to get discharged from hospital.

Sponsors

University of Cologne
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients who get OPAT

Exclusion criteria

* patients who don't get OPAT

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients with effective OPAT12 weeksSuccessful administration and completion of the antiinfective therapy
Number of Patients With Treatment-Related Adverse Events12 weeksside-effects of treatment and catheter-related infections
Number of Hospitals being able to apply OPAT12 weeksFeasibility of OPAT under differing hospital specific circumstances

Countries

Germany

Contacts

Primary ContactClara Lehmann, Prof.
clara.lehmann@uk-koeln.de+4922147839684
Backup ContactCharlotte Leisse
charlotte.leisse@uk-koeln.de+4922147842895

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026